Economic Price and Productivity Measurement in a Pharmaceutical Sub-sector - Treating Hypertension

Project number: 
00-021
Approval date: 
Tuesday, November 28, 2000
Principal Investigator: 
Morgan,Steve
Institution: 
Not Available
Funding Agency: 
Not Available
Datasets requested: 
Not available
Research objective: 
Publications: 

Journal Publication

  • Morgan, S.G.; Bassett, K.; Wright, J.; Yan, L. (2005) "First-line first? Trends in thiazide prescribing for BC seniors." PLoS Medicine 2(4): e80-e87
  • Morgan, S.G.; Yan, L. (2004)  "Persistence with hypertension treatment among community-dwelling BC seniors." Canadian Journal of Clinical Pharmacology 11(2): e267-e273
  • Morgan, S. (2002) "Quantifying components of drug expenditure inflation: The British Columbia seniors’ drug benefit plan." Health Services Research 37(5): 1243-1266
  • Morgan, S. (2001) "Statistics and drug utilization: Are prescribing rates really that high?" Canadian Medical Association Journal 165(11): 1507-1508

Presentation of research material (poster/seminar/lecture etc.)

  • Morgan, S. "Measuring ‘quality,’ ‘accessibility.’ and ‘sustainability’ – Are drugs part of the problem or part of the solution?” Tools For Advancing Pharmaceuticals Management. Canadian Coordinating Office for Health Technology Assessment; Canadian Institute for Health Information; Health Canada, Therapeutic Products Directorate; and the Patented Medicine Prices Review Board, Ottawa, November 2004
  • Morgan, S. "Sources of drug spending trends and variations in Canada." Pharmaceutical Policy, hearings of the House of Commons Standing Committee on Health, Vancouver, September 2003
  • Morgan, S. "Pharmaceuticals as a cost driver in Canada.Toward a National Strategy on Drug Insurance: Challenges and Priorities." Institute for Research on Public Policy, Toronto, September 2002
  • Morgan, S. "Drug spending trends: The devil in the details." Policy Rounds Forum, British Columbia Ministry of Health and Ministry Responsible for Seniors, Victoria, January 2001

Conference abstract/presentation

  • Morgan, S; Barer, M.; Agnew, J. "Seniors’ cost-inflation and cost-containment: Evidence from British Columbia." Fourth World Congress of the International Health Economics Association, San Francisco, June 2003
  • Morgan, S. "Quantifying components of drug expenditure inflation: The British Columbia seniors’ drug benefit plan." Tenth Canadian Conference on Health Economics, Halifax, May 2002
     
  • Morgan, S.G. "Productivity measurement in a pharmaceutical sub-sector: The real cost of treating hypertension." 34th Annual Meeting of the Canadian Economics Association, Vancouver, June 2000

Page last revised: December 5, 2017